Long-term sero-positivity for IgG, sequelae of respiratory symptoms, and abundance of malformed sperms in a patient recovered from severe COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term sero-positivity for IgG, sequelae of respiratory symptoms, and abundance of malformed sperms in a patient recovered from severe COVID-19
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-09
DOI
10.1007/s10096-021-04178-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)
- (2020) Fang Jiang et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Coronavirus Disease 2019 (COVID-19): A Perspective from China
- (2020) Zi Yue Zu et al. RADIOLOGY
- Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China
- (2020) Zhiliang Hu et al. Science China-Life Sciences
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Nervous system involvement after infection with COVID-19 and other coronaviruses
- (2020) Yeshun Wu et al. BRAIN BEHAVIOR AND IMMUNITY
- Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
- (2020) Songping Cui et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China
- (2020) Hua Su et al. KIDNEY INTERNATIONAL
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19
- (2020) Jiewen Fu et al. MOLECULAR BIOLOGY REPORTS
- A human neutralizing antibody targets the receptor binding site of SARS-CoV-2
- (2020) Rui Shi et al. NATURE
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- SARS-CoV-2 infection protects against rechallenge in rhesus macaques
- (2020) Abishek Chandrashekar et al. SCIENCE
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
- (2020) Ling Mao et al. JAMA Neurology
- scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells
- (2020) Zhengpin Wang et al. Cells
- No evidence of severe acute respiratory syndrome–coronavirus 2 in semen of males recovering from coronavirus disease 2019
- (2020) Feng Pan et al. FERTILITY AND STERILITY
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
- (2020) Qing Ye et al. JOURNAL OF INFECTION
- Extrapulmonary manifestations of COVID-19
- (2020) Aakriti Gupta et al. NATURE MEDICINE
- Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques
- (2020) Wei Deng et al. SCIENCE
- Autopsy of COVID-19 victims in China
- (2020) Xiu-Wu Bian et al. National Science Review
- Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease 2019
- (2020) Diangeng Li et al. JAMA Network Open
- A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
- (2020) Angkana T. Huang et al. Nature Communications
- Cytokine storm and sepsis disease pathogenesis
- (2017) Benjamin G. Chousterman et al. Seminars in Immunopathology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started